Malignant pleural mesothelioma: Comparison of radical pleurectomy und extrapleural pneumonectomy;Malignes Pleuramesotheliom: Radikale Pleurektomie und extrapleurale Pneumonektomie im Vergleich

Chirurg

Volumn 84, Issue 6, 2013, Pages 487-491

  Bolukbas S ^a   Schirren, J ^a  

^a DR HORST SCHMIDT KLINIKEN   (Germany)

Author keywords

Extrapleural pneumonectomy; Malignant pleural mesothelioma; Radical pleurectomy; Surgical technique; Treatment outcome

Indexed keywords

CANCER STAGING; COMPARATIVE STUDY; DISEASE COURSE; HEALTH STATUS INDICATOR; HUMAN; LUNG RESECTION; MESOTHELIOMA; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PLEURA; PLEURA TUMOR; POSTOPERATIVE COMPLICATION; PROGNOSIS; REVIEW; SURVIVAL RATE; TUMOR RECURRENCE;

COMBINED MODALITY THERAPY; DISEASE PROGRESSION; HEALTH STATUS INDICATORS; HUMANS; MESOTHELIOMA; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PLEURA; PLEURAL NEOPLASMS; PNEUMONECTOMY; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; SURVIVAL RATE;

EID: 84878998184     PISSN: 00094722     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00104-012-2432-5     Document Type: Review

References (30)

1. Ambrogi V, Mineo D, Gatti A et al (2009) Symptomatic and quality of life changes after extrapleural pneumonectomy for malignant pleural mesothelioma. J Surg Oncol 100(3):199-204
2. Baldini EH, Recht A, Strauss GM et al (1997) Patterns of failure after trimodality therapy for malignant pleural mesothelioma. Ann Thorac Surg 63:334-338
3. Bölükbas S, Eberlein M, Schirren J (2012) Prospective study on functional results after lung-sparing radical pleurectomy in the management of malignant pleural mesothelioma. J Thorac Oncol 7(5):900-905
4. Bölükbas S, Eberlein M, Schirren J (2012) Video-atlas of radical pleurectomy for malignant pleural mesothelioma/title. Ann Cardiothorac Surg. doi:10.3978/j.issn.2225-319X.2012.10.06
5. Bölükbas S, Manegold C, Eberlein M et al (2011) Survival after trimodality therapy for malignant pleural mesothelioma: radical pleurectomy, chemotherapy with Cisplatin/Permetrexed and radiotherapy. Lung Cancer 71(1):75-81
6. Branscheid D, Krysa S, Bauer E et al (1991) Diagnostic and therapeutic strategy in malignant pleural mesothelioma. Eur J Cardiothorac Surg 5:466-472
7. Cao C, Tian D, Manganas C et al (2012) Systematic review of trimodality therapy for patients with malignant pleural mesothelioma. Ann Cardiothorac Surg 1(4):428-437. doi:10.3978/j.issn.2225-319X.2012.11.07
8. Perrot M de, Feld R, Cho BCJ et al (2009) Trimodality therapy with induction chemotherapy followed by extrapleural pneumonectomy and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Clin Oncol 27:1413-1418
9. Flores RM, Pass HI, Seshan VE et al (2008) Extrapleural pneumonectomy versus pleurectomy in the surgical management of malignant pleural mesothelioma: results in 663 patients. J Thorac Cardiovasc Surg 135:620-626
10. Friedberg JS, Culligan MJ, Mick R et al (2012) Radical pleurectomy and intraoperative photodynamic therapy for malignant pleural mesothelioma. Ann Thorac Surg 93:1658-1667
11. Friedberg JS, Mick R, Culligan M et al (2011) Photodynamic therapy and the evolution of a lung-sparing surgical treatment for mesothelioma. Ann Thorac Surg 91:1738-1745
12. Jassem J, Ramlau R, Santoro A et al (2008) Phase III trial of pemetrexed plus best supportive care compared with best supportive care in previously treated patients with advanced malignant pleural mesothelioma. J Clin Oncol 26:1698-1704
13. Krug LM, Pass HI, Rusch VW et al (2009) Multicenter phase II trial of neoadjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy and radiation for malignant pleural mesothelioma. J Clin Oncol 27:3007-3013
14. Lang-Lazdunski L, Bille A, Lal R et al (2012) Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma. J Thorac Oncol 7(4):737-743
15. Manegold C, Symanowski J, Gatzemeier U et al (2005) Second-line (post-study) chemotherapy received by patients treated in the phase III trial of pemetrexed plus cisplatin versus cisplatin alone in malignant pleural mesothelioma. Ann Oncol 16:923-927
16. Martini N, Bains MS, Beattie EJ Jr (1975) Indications for pleurectomy in malignant effusion. Cancer 35(3):734-738
17. Mollberg NM, Vigneswaran Y, Kindler HL et al (2012) Quality of life after radical pleurectomy decortication for malignant pleural mesothelioma. Ann Thorac Surg 94:1086-1092
18. Ramalingam SS, Belani CP (2008) Recent advances in the treatment of malignant pleural mesothelioma. J Thorac Oncol 3(9):1056-1064
19. Rice D, Rusch V, Pass H et al (2011) Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 6(8):1304-1312
20. Ried M, Potzger T, Braune N et al (2012) Cytoreductive surgery and hyperthermic intrathoracic chemotherapy perfusion for malignant pleural tumours: perioperative management and clinical experience. Eur J Cardiothorac Surg (10.1093/ejcts/ezs418)
21. Rusch VW, Rosenzweig K, Venkatraman E et al (2001) A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg 122:788
22. Rusch VW, Venkatraman ES (1999) Important prognostic factors in patients with malignant pleural mesothelioma managed surgically. Ann Thorac Surg 68:1799-1804
23. Schipper PH, Nichols FC, Thomse KM et al (2008) Malignant pleural mesothelioma: surgical management in 285 patients. Ann Thorac Surg 85:257-264
24. Sugarbaker DJ (2006) Macroscopic complete resection: the goal of primary surgery in multimodality therapy for pleural mesothelioma. J Thorac Oncol 1(2):175-176
25. Sugarbaker DJ, Flores RM, Jaklitsch MT et al (1999) Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg 117:54
26. Treasure T, Internullo E, Fiorentino F et al (2011) A survey of opinions and beliefs concerning surgery for malignant pleural mesothelioma amongst 802 members of the European Association for Cardio-Thoracic Surgery (EACTS), the European Society of Thoracic Surgeons (ESTS) and the Society of Thoracic Surgeons (STS). Interact Cardiovasc Thorac Surg 12:341-346
27. Tilleman TR, Richards WG, Zellos L et al (2009) Extrapleural pneumonectomy followed by intracavitary intraoperative hyperthermic cisplatin with pharmacologic cytoprotection for treatment of malignant pleural mesothelioma: a phase II prospective study. J Thorac Cardiovasc Surg 138:405-411
28. Tselis N, Ferentinos K, Kolotas C et al (2011) Computed tomography-guided interstitial high-dose-rate brachytherapy in the local treatment of primary and secondary intrathoracic malignancies. J Thorac Oncol 6(3):545-552
29. Utley M, Fiorentino F, Treasure T (2010) Obtaining an upper estimate of the survival benefit associated with surgery for mesothelioma. Eur J Cardiothorac Surg 38:241-244
30. Weder W, Stahel RA, Bernhard J et al (2007) Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma. Ann Onc 18:1196-1202